Nice Prostate Cancer. Prostate cancer is a malignant tumour of the prostate. New guidelines for treating and diagnosing prostate cancer on the nhs have been published for consultation today by the national institute for health and care.
/prostate-cancer-diagnosis-5b47774d46e0fb0054930f2b.png)
We use the best available evidence to develop. In 2021, nice rejected lynparza for this indication and then again earlier this year, in a decision that was underpinned by issues around cost, since the regulator had stated the. This information should be given by a healthcare professional (for example, a consultant or specialist nurse).
